Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-β.
about
Poor responses to interferon-beta treatment in patients with neuromyelitis optica and multiple sclerosis with long spinal cord lesions.Cytokines as Biomarkers of Treatment Response to IFN β in Relapsing-Remitting Multiple SclerosisBody fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the futureThe Role of IL-17 and Th17 Lymphocytes in Autoimmune DiseasesInterluekin-17A (IL17A).A comparison of HMGB1 concentrations between cerebrospinal fluid and blood in patients with neurological disease.Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study.Inflammatory cytokines at the summits of pathological signal cascades in brain diseases.Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis.Anti-IL-23 and Anti-IL-17 Biologic Agents for the Treatment of Immune-Mediated Inflammatory Conditions.Characterization of IL-17AA and IL-17FF in rheumatoid arthritis and multiple sclerosis.
P2860
Q33699532-A3BADF58-6DD3-475D-9364-9B76340A259FQ34053077-0A2F28A8-EE99-4FDD-99A3-787AB3FBD6BBQ35078327-3DAE2757-41AD-49E9-8916-9E83AB9A5F04Q36249305-54554CAA-9C1F-4829-B89A-F03F7F589801Q39103136-1715A7EE-C55D-4337-A8DC-7565FA0FF34BQ40431064-AA0E4B91-7FD7-4080-9C21-E54846143352Q40688945-2DE2C975-369C-4971-93AE-E6B5F031D6D8Q44433702-CAA5DC50-C8B4-47C1-94B3-078E07202CF2Q47559443-44E9FB56-42CA-48CF-A866-EB0E1AD590EBQ47727612-BD5B9040-1047-4A3F-A0F7-83A218878A00Q51515919-B889B0A5-65EF-4CA7-9D3F-CC6DA7609D2C
P2860
Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-β.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Serum levels of IL-17A in pati ...... sis treated with interferon-β.
@en
Serum levels of IL-17A in pati ...... sis treated with interferon-β.
@nl
type
label
Serum levels of IL-17A in pati ...... sis treated with interferon-β.
@en
Serum levels of IL-17A in pati ...... sis treated with interferon-β.
@nl
prefLabel
Serum levels of IL-17A in pati ...... sis treated with interferon-β.
@en
Serum levels of IL-17A in pati ...... sis treated with interferon-β.
@nl
P2860
P356
P1476
Serum levels of IL-17A in pati ...... osis treated with interferon-β
@en
P2093
Adina Huţanu
Zoltan Bajko
P2860
P304
P356
10.1177/1352458512468497
P577
2012-12-03T00:00:00Z